Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia – A Phase 3 Study

By Roth Eli   Rosenson Robert   Carlson Dawn   Fukumoto Sandra   Setze Carolyn   Blasetto James   Khurmi Nardev   Stolzenbach James   Williams Laura  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 421-428

Springer Publishing Company

Access to resources Recommend Favorite

Fenofibric Acid: In Combination Therapy in the Treatment of Mixed Dyslipidemia

By Yang Lily P.H.   Keating Gillian M.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 6, 2009-12 ,pp. : 401-409

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and Hypertriglyceridemia: A Randomized, Double-Blind Study

By Roth Eli M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 3, 2010-06 ,pp. : 175-186

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 73-84

Adis International

Access to resources Recommend Favorite

Long-Term Efficacy of Adding Fenofibric Acid to Moderate-Dose Statin Therapy in Patients with Persistent Elevated Triglycerides

By Ballantyne Christie   Jones Peter   Kelly Maureen   Setze Carolyn   Lele Aditya   Thakker Kamlesh   Stolzenbach James  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 1, 2011-02 ,pp. : 59-67

Springer Publishing Company

Access to resources Recommend Favorite